NYSE:CNCO 1 March 2026

Chile stocks week ahead: IPSA faces MSCI aftershocks, SQM results and key data

Chile’s S&P CLX IPSA index closed Friday at 10,877.74, down 1.56%, capping a 4.8% monthly drop—its worst since October 2023—amid MSCI-driven repositioning. Retailers and banks led declines; Cencosud fell 5.95%. The peso weakened to 873.71 per dollar. The central bank will release January IMACEC data Monday, and SQM reported 2025 net income of $588.1 million.

1 March 2026

NYSE:CNCO·NYSE:ITUB·NYSE:SQM·NYSE:VAP·Stock Market

Pro Medicus (ASX:PME) Valuation Faces Mixed Signals After Leadership Changes
March 22, 2026, 12:50 AM EDT. Pro Medicus (ASX:PME) has restructured its senior leadership, appointing Danny English as CFO and moving Clayton Hatch to combined operational roles. The stock trades at A$120.06, down 2.09% in one day and 46.07% year-to-date, despite a strong 5-year total return of 173.62%. Analysts suggest the company is 39% undervalued with a fair value at A$196.78, citing steady revenue growth and expanding market potential. However, its high price-to-earnings (P/E) ratio of 53.4x exceeds peers and fair estimates, posing a valuation risk if growth expectations are not met. Key risks include accelerated AI adoption in imaging and contract delays with U.S. hospitals. Investors face a split market sentiment on PME's true value amid recent leadership changes and performance concerns.